Apotex, Inc. v. Sebelius
Petition for certiorari denied on January 18, 2011
Issue: Whether a generic drug manufacturer may forfeit marketing exclusivity under 21 U.S.C. § 355(j)(5)(D) based on “unilateral”? action by the holder of the challenged patent.
SCOTUSblog Coverage
- Petition of the day (Conor McEvily, October 29, 2010)
Briefs and Documents
Certiorari-stage documents
- Petition for certiorari
- Brief in opposition
- Brief for federal respondents in opposition
- Amicus brief of AARP and the Consumer Federation of America
- Petitioner's reply
[##CERT-STAGE##]